• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[转移性乳腺癌化疗后发生的细胞抑制性肺病]

[Cytostatic pneumopathy following chemotherapy for metastasizing breast neoplasm].

作者信息

Flubacher P, Meier V, Obrecht J P, Hartmann D

出版信息

Schweiz Med Wochenschr. 1977 Oct 8;107(40):1412-7.

PMID:918593
Abstract

A 69-year-old patient treated with anticancer polychemotherapy for metastatic breast carcinoma died of respiratory distress and cardiac failure 3 months after commencement of therapy. At autopsy only a few pleural micrometastases were found. Microscopic study revealed early lung lesions due to cytotoxic drug treatment. While the earlier literature described different lesions associated with different antineoplastic drugs (busulfan, bleomycin), today there is more emphasis on the common pathological features. Therefore, instead of the expressions "busulfan lung" or "bleomycin lung", we suggest the use of the term "Zytostatika-Pneumopathie" (cytostatic drug induced lung disease).

摘要

一名69岁接受转移性乳腺癌多药联合抗癌化疗的患者在治疗开始3个月后死于呼吸窘迫和心力衰竭。尸检仅发现少数胸膜微转移灶。显微镜检查显示为细胞毒性药物治疗引起的早期肺部病变。虽然早期文献描述了与不同抗肿瘤药物(白消安、博来霉素)相关的不同病变,但如今更强调其共同的病理特征。因此,我们建议不再使用“白消安肺”或“博来霉素肺”等表述,而是使用“细胞毒性药物所致肺病”这一术语。

相似文献

1
[Cytostatic pneumopathy following chemotherapy for metastasizing breast neoplasm].[转移性乳腺癌化疗后发生的细胞抑制性肺病]
Schweiz Med Wochenschr. 1977 Oct 8;107(40):1412-7.
2
[Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
Schweiz Med Wochenschr. 1974 Aug 3;104(31):1077-85.
3
[Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
Ugeskr Laeger. 1977 Oct 31;139(44):2632-5.
4
[Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
Internist (Berl). 1973 Dec;14(12):643-52.
5
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱和泼尼松辅助化疗与单药左旋苯丙氨酸氮芥治疗可手术乳腺癌且腋窝淋巴结阳性患者的比较:西南肿瘤协作组20年研究结果
Cancer. 2003 Jan 1;97(1):21-9. doi: 10.1002/cncr.10982.
6
[Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
Med Klin. 1976 Oct 1;71(40):1676-83.
7
[Chemotherapy of metastasizing breast cancers. Indications and results].
Dtsch Med Wochenschr. 1975 Jan 10;100(2):35-41. doi: 10.1055/s-0028-1106166.
8
[Cytostatic combination therapy in metastatic breast cancer].
Ugeskr Laeger. 1973 Jun 18;135(25):1336-40.
9
[Association of VCR-5FU-CYCLO-PDN in the treatment of disseminated carcinoma of the breast (author's transl)].VCR - 5FU - 环磷酰胺 - 强的松龙联合治疗播散性乳腺癌(作者译)
Med Clin (Barc). 1979 Aug 15;73(4):136-9.
10
Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.转移性乳腺癌的联合与序贯五药化疗对比研究
Cancer Res. 1976 Nov;36(11 Pt 1):3911-6.